David Good

Title: David Good - Innovator in Poly Alpha-1,6-Glucan Derivatives

Introduction

David Good is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of biochemistry, particularly through his innovative work on poly alpha-1,6-glucan derivatives. His research has implications for various applications in the industry.

Latest Patents

David Good holds a patent for "Poly alpha-1,6-glucan derivatives and compositions comprising same." This patent describes poly alpha-1,6-glucan derivatives that are substituted with at least one organic group linked through a variety of moieties, including ether, sulfonyl, carbonate, or carbamoyl/carbamate. The degree of substitution ranges from about 0.001 to about 3.0. The backbone of these derivatives consists of glucose monomer units, with at least 40% linked via alpha-1,6 glycosidic linkages, and optionally includes branches via alpha-1,2 and/or alpha-1,3 glycosidic linkages. These compositions can be utilized in various applications, showcasing the versatility of his invention.

Career Highlights

David Good is currently associated with Nutrition & Biosciences USA 4, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key player in the field of biosciences, contributing to innovative solutions that address industry needs.

Collaborations

David collaborates with esteemed colleagues, including Zhengzheng Huang and Douglas J. Adelman. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

David Good's contributions to the field of poly alpha-1,6-glucan derivatives exemplify the impact of innovative research in biochemistry. His work not only advances scientific understanding but also opens new avenues for practical applications in various industries.